These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27729735)

  • 1. Recent advances in mass spectrometry-based proteomics of gastric cancer.
    Kang C; Lee Y; Lee JE
    World J Gastroenterol; 2016 Oct; 22(37):8283-8293. PubMed ID: 27729735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of mass spectrometry in proteomics.
    Guerrera IC; Kleiner O
    Biosci Rep; 2005; 25(1-2):71-93. PubMed ID: 16222421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry for protein identification and the study of post translational modifications.
    Salzano AM; Crescenzi M
    Ann Ist Super Sanita; 2005; 41(4):443-50. PubMed ID: 16569912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
    Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
    J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What gastric cancer proteomic studies show about gastric carcinogenesis?
    Leal MF; Wisnieski F; de Oliveira Gigek C; do Santos LC; Calcagno DQ; Burbano RR; Smith MC
    Tumour Biol; 2016 Aug; 37(8):9991-10010. PubMed ID: 27126070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difference analysis on proteome of Helicobacter pylori in patients with peptic ulcer, gastritis, and gastric cancer].
    Zhang J; Ding SG; Zhong LJ; Lin SR; Yang B; Peng JR; Lou YX
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2690-4. PubMed ID: 17199978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in quantitative proteomics using stable isotope tags.
    Flory MR; Griffin TJ; Martin D; Aebersold R
    Trends Biotechnol; 2002 Dec; 20(12 Suppl):S23-9. PubMed ID: 12570156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
    Mohri Y; Toiyama Y; Kusunoki M
    Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
    Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of food proteins and peptides by mass spectrometry-based techniques.
    Mamone G; Picariello G; Caira S; Addeo F; Ferranti P
    J Chromatogr A; 2009 Oct; 1216(43):7130-42. PubMed ID: 19699482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in top-down proteomics for disease biomarker discovery.
    Calligaris D; Villard C; Lafitte D
    J Proteomics; 2011 Jun; 74(7):920-34. PubMed ID: 21477672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker.
    Tseng CW; Yang JC; Chen CN; Huang HC; Chuang KN; Lin CC; Lai HS; Lee PH; Chang KJ; Juan HF
    Proteomics; 2011 Jun; 11(12):2423-39. PubMed ID: 21598387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology.
    Hao Y; Yu Y; Wang L; Yan M; Ji J; Qu Y; Zhang J; Liu B; Zhu Z
    J Proteome Res; 2008 Sep; 7(9):3668-77. PubMed ID: 18680356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
    Oh JH; Pan S; Zhang J; Gao J
    Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow field-flow fractionation: a pre-analytical method for proteomics.
    Reschiglian P; Moon MH
    J Proteomics; 2008 Aug; 71(3):265-76. PubMed ID: 18602503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving in-depth proteomics profiling by mass spectrometry.
    Ahn NG; Shabb JB; Old WM; Resing KA
    ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
    Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
    Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
    Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
    Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based proteomics in the life sciences.
    Lane CS
    Cell Mol Life Sci; 2005 Apr; 62(7-8):848-69. PubMed ID: 15868409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.